128 related articles for article (PubMed ID: 27655540)
21. [Silencing DNMT1 Attenuates the Effect of WIF-1 Gene Promoter Methylation on the Biological Behavior of Chronic Myeloid Leukemia K562 Cells].
Wu K; Jin Z; Li YX; Li X; Cheng SJ; Li YH; Guo C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Dec; 29(6):1768-1774. PubMed ID: 34893108
[TBL] [Abstract][Full Text] [Related]
22. Impact of WNT Pathway Blockade on the Biological Characteristics of Renal Tubular Epithelial Cells Stably Transfected with PAX2.
Li L; Gong L
Ann Clin Lab Sci; 2021 May; 51(3):368-375. PubMed ID: 34162567
[TBL] [Abstract][Full Text] [Related]
23. The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells.
Cao L; Gao H; Li P; Gui S; Zhang Y
Tumour Biol; 2014 Jun; 35(6):5121-7. PubMed ID: 24643679
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of dishevelled proteins in the Wnt pathway in childhood acute lymphoblastic leukemia].
Wang WP; Guo L; Li Y; Lu LH; Chang Y; Zhou B; Zhou M; Li X; Gao JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2019 May; 21(5):411-414. PubMed ID: 31104653
[TBL] [Abstract][Full Text] [Related]
25. Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.
Leal LF; Mermejo LM; Ramalho LZ; Martinelli CE; Yunes JA; Seidinger AL; Mastellaro MJ; Cardinalli IA; Brandalise SR; Moreira AC; Tone LG; Scrideli CA; Castro M; Antonini SR
J Clin Endocrinol Metab; 2011 Oct; 96(10):3106-14. PubMed ID: 21849527
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of miR-155 Promoting Drug Resistance in Childhood Acute Lymphoblastic Leukemia by Regulating Wnt/β-Catenin Signaling Pathway].
Huang HM; Wei YJ; Wang D; Wen XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):418-424. PubMed ID: 35395973
[TBL] [Abstract][Full Text] [Related]
27. [The Mechanism of miR-1294 Targeting
Cen HX; Cai SM; Jiang HY; Liao ZM; Han DG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):344-351. PubMed ID: 37096504
[TBL] [Abstract][Full Text] [Related]
28. The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer.
Liu YL; Yang HP; Zhou XD; Gong L; Tang CL; Wang HJ
Curr Cancer Drug Targets; 2011 Nov; 11(9):1098-110. PubMed ID: 21933103
[TBL] [Abstract][Full Text] [Related]
29. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
Rubin EM; Guo Y; Tu K; Xie J; Zi X; Hoang BH
Mol Cancer Ther; 2010 Mar; 9(3):731-41. PubMed ID: 20197388
[TBL] [Abstract][Full Text] [Related]
30. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.
Ge XS; Ma HJ; Zheng XH; Ruan HL; Liao XY; Xue WQ; Chen YB; Zhang Y; Jia WH
Cancer Sci; 2013 Dec; 104(12):1675-82. PubMed ID: 24118380
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
[TBL] [Abstract][Full Text] [Related]
32. Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma.
Ding Z; Qian YB; Zhu LX; Xiong QR
World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
[TBL] [Abstract][Full Text] [Related]
33. Suppression of WIF-1 through promoter hypermethylation causes accelerated proliferation of the aryl hydrocarbon receptor (AHR) overexpressing MCF10AT1 breast cancer cells.
Wu D; Wong P; Li W; Vogel CF; Matsumura F
Toxicology; 2011 Jul; 285(3):97-103. PubMed ID: 21515334
[TBL] [Abstract][Full Text] [Related]
34. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
35. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
36. Infrequent hypermethylation of WIF-1 promoter in BCR/ABL-negative myeloproliferative disorders.
Suzuki R; Onizuka M; Kojima M; Shimada M; Tsuboi K; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2007 Dec; 32(4):131-5. PubMed ID: 21318952
[TBL] [Abstract][Full Text] [Related]
37. A long non-coding RNA, HOTAIR, promotes cartilage degradation in osteoarthritis by inhibiting WIF-1 expression and activating Wnt pathway.
Yang Y; Xing D; Wang Y; Jia H; Li B; Li JJ
BMC Mol Cell Biol; 2020 Jul; 21(1):53. PubMed ID: 32650720
[TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract][Full Text] [Related]
39. Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemia.
Chim CS; Fung TK; Wong KF; Lau JS; Liang R
Leuk Res; 2006 Sep; 30(9):1135-9. PubMed ID: 16427695
[TBL] [Abstract][Full Text] [Related]
40. Role of Wnt inhibitory factor-1 and Wnt/wingless signaling in choroid plexus tumors.
Tomm M; Koch A; Mertsch S; Wrede B; Jeibmann A; Wolff J; Paulus W; Hasselblatt M
Pediatr Blood Cancer; 2009 Dec; 53(6):1152-5. PubMed ID: 19621428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]